Accelerate the timeline from gene to lead cline with new GS Ori-Go® vector Drug developers face tremendous pressure to increase efficiency and productivity, and reduce development timelines. At Lonza, focused innovation efforts aimed at addressing these demands have yielded a number of advances in core technologies within the well-established and trusted GS Gene Expression System® platform. The latest advancement, the GS Ori-Go® vector system, harnesses a novel method of glutamine s
CryptoAlerta — análise de criptomoedas e mercado em tempo real